Madhya Pradesh
Madhya Pradesh: DRI seizes 112 kg Mephedrone
- 14 Oct 2024
- 3 min read
Why in News?
Recently, the Directorate of Revenue Intelligence (DRI) busted an illegal mephedrone factory in Jhabua, Madhya Pradesh, seizing a large quantity of narcotics.
Key Points
- DRI Operation in Jhabua: The Directorate of Revenue Intelligence (DRI) uncovered an illegal factory manufacturing mephedrone in Jhabua, Madhya Pradesh.
- The operation led to the seizure of 112 kg of mephedrone, a synthetic drug, with a high street value.
- Multiple individuals involved in the illegal drug manufacturing and distribution network were arrested during the operation.
- Impact on Drug Trafficking: The bust is considered a significant blow to narcotics trafficking in the region, as mephedrone is a popular illegal drug in the market.
- Continued Vigilance: Authorities have increased vigilance and are monitoring the area to prevent further illegal drug activities in the region.
- Mephedrone and its Risks: Mephedrone, also known as "meow meow" or "MD," is a highly addictive synthetic drug, with severe health risks, making its illegal production a priority for law enforcement to tackle.
Mephedrone
- It is also known as 4-methylmethcathinone, 4-MMC and 4-methylephedrone.
- It is a synthetic stimulant drug of the amphetamine and cathinone classes.
- Other names: drone, M-CAT, white magic, ‘meow meow’, and bubble.
- It has a role as a xenobiotic and an environmental contaminant.
- It has been linked to a range of adverse effects on both physical and mental health.
- Users commonly report increased alertness, euphoria, and enhanced sociability, but these positive effects come at a cost.
- Health impacts:
- Anxiety, paranoia, nausea, and insomnia are among the negative side effects experienced by individuals under the influence of this synthetic stimulant.
- Prolonged use of Mephedrone has been associated with more severe consequences, including cardiovascular issues, hallucinations, and even instances of aggressive behaviour.
- The drug's impact on mental health raises concerns about its potential for addiction and long-term psychological harm.
- It is banned in India under the Narcotic Drugs and Psychotropic Substances Act, 1985.
